Rima I Ghamrawi (R I Ghamrawi, Rima Ghamrawi)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 11

Top Topics

Peritoneal Dialysis

Clinical Evaluation

Peripheral Artery Disease

Top Venues

American journal of clinical dermatology

The Journal of dermatological treatment

The Annals of pharmacotherapy

ImmunoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Karan Pandher, Rima I Ghamrawi, Courtney E Heron, Steven Richard Feldman
Controversial cardiovascular and hematologic comorbidities in atopic dermatitis. Archives of dermatological research (2021)
Steven A Svoboda, Rima I Ghamrawi, Dorellie A Owusu, Steven Richard Feldman
Treatment Goals in Psoriasis: Which Outcomes Matter Most? American journal of clinical dermatology 21 (4) (2021)
Rima I Ghamrawi, Katheryn A Bell, Esther A Balogh, Lindsay C Strowd, Steven Richard Feldman
Current and emerging biologics for the treatment of pediatric atopic dermatitis. Expert opinion on biological therapy 20 (12) (2020)
Alexander N Howell, Rima I Ghamrawi, Lindsay C Strowd, Steven Richard Feldman
Pharmacological management of atopic dermatitis in the elderly. Expert opinion on pharmacotherapy 21 (7) (2020)
Rima I Ghamrawi, Neda Ghiam, Jashin J Wu
Comparison of psoriasis guidelines for use of apremilast in the United States and Europe: a critical appraisal and comprehensive review. The Journal of dermatological treatment (2020)
Mary Beth Gadarowski, Rima I Ghamrawi, Sarah L Taylor, Steven R Feldman
PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines. The Annals of pharmacotherapy 55 (3) (2020)
Rima I Ghamrawi, Neda Ghiam, Jashin J Wu
Comparison of psoriasis guidelines for use of IL-23 inhibitors in the United States and United Kingdom: a critical appraisal and comprehensive review. The Journal of dermatological treatment (2020)
Esther A Balogh, Arjun M Bashyam, Rima I Ghamrawi, Steven Richard Feldman
Emerging systemic drugs in the treatment of plaque psoriasis. Expert opinion on emerging drugs 25 (2) (2020)
Scott H Berg, Esther A Balogh, Rima I Ghamrawi, Steven Richard Feldman
A review of secukinumab in psoriasis treatment. Immunotherapy 13 (3) (2020)
Courtney E Heron, Rima I Ghamrawi, Esther A Balogh, Steven Richard Feldman
Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity Detection. American journal of clinical dermatology 22 (2) (2020)
Rhea Singh, Courtney E Heron, Rima I Ghamrawi, Lindsay C Strowd, Steven Richard Feldman
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. ImmunoTargets and therapy 9 (2020)